N. Kalyanam

Dr. N. Kalyanam is the President of Sabinsa’s New Jersey R&D. His research interests are synthetic methodology and chiral chemistry. He obtained his M.Sc. in Chemistry at the University of Madras and Ph.D. in Organic Chemistry from Baylor University (Texas). Upon completing his Ph.D., Dr. Kalyanam completed 2 years of postdoctoral studies focusing on organic synthesis procedures before returning to India. In India he worked for a number of reputable companies, IPCL, Ciba Geigy, and SPIC Pharma, to which he made major scientific contributions.

Dr. Kalyanam’s primary responsibilities at Sabinsa include the development of efficient and novel scientific routes for xenobiotics and intermediates as well as the exploration of new business areas.